GSK Pharma Q3 profit rises 7

8220;The growth sales was impacted due to lower selling prices as a result of excise duty reduction being passed on to the consumer,8221; the company said.

For the nine-month period ended September 30,2009,the drug maker posted a net profit of Rs 408.70 crore,up 11 per cent as compared to Rs 368.10 crore of the same period a year ago.

Shares of GSK Pharma were trading at Rs 1,600,marginally down by 0.04 per cent in the afternoon trade on the BSE.